Understanding the genetic basis of hereditary diffuse gastric cancer

Gastric cancer, a significant global health burden, claims over 7% of cancer-related deaths annually. Although only 1-3% of cases have a genetic basis, understanding these genetic drivers is crucial for developing preventative strategies.

Bio-Thera, Biomm enter licensing deal for ustekinumab biosimilar

Bio-Thera’s BAT2206 is approved to treat moderate to severe plaque psoriasis patients aged six years or above. Credit: Ternavskaia Olga Alibec via shutterstock.com. Bio-Thera Solutions

June 19, 2023

Nxera partners Antiverse to design antibodies targeting GPCRs

The initial project will focus on antibodies’ design with agonistic function for a demanding GPCR target. Credit: SmartPhotoLab/Shutterstock. Nxera Pharma, previously known as Sosei Heptares

November 6, 2024

Pharma ads get caught by stricter Meta enforcement in election year

Meta is looking to differentiate itself as a “safe” social media platform, but insiders say more ads made by pharma companies including Sanofi and Gilead

February 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.